2017
DOI: 10.1016/j.cbi.2017.04.020
|View full text |Cite
|
Sign up to set email alerts
|

Investigating the potential of Oxymatrine as a psoriasis therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
12
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 24 publications
(12 citation statements)
references
References 65 publications
0
12
0
Order By: Relevance
“…This suggestion seems to be borne out in practice (Saxena and Dogra, 2005, 2010; Walecka et al, 2009). Finally, if inflammation is a cause and not a manifestation, one may anticipate that anti-inflammatories might also be of value (Aggarwal and Harikumar, 2008; Kang et al, 2016; Chen et al, 2017; Sharma et al, 2017; Kerley et al, 2018; Owczarczyk-Saczonek et al, 2018).…”
Section: Implications For Treatmentmentioning
confidence: 99%
“…This suggestion seems to be borne out in practice (Saxena and Dogra, 2005, 2010; Walecka et al, 2009). Finally, if inflammation is a cause and not a manifestation, one may anticipate that anti-inflammatories might also be of value (Aggarwal and Harikumar, 2008; Kang et al, 2016; Chen et al, 2017; Sharma et al, 2017; Kerley et al, 2018; Owczarczyk-Saczonek et al, 2018).…”
Section: Implications For Treatmentmentioning
confidence: 99%
“…Matrine synergized with acitretin to induce cell cycle arrest and autophagy in keratinocytes by regulating PI3K/Akt/mTOR pathway (Jiang et al, 2019). Oxymatrine ameliorated skin inflammation in the patients with psoriasis and psoriasis-like mouse model via inhibiting keratinocyte proliferation probably through MAPK signaling pathway (Chen et al, 2017;Zhou et al, 2017;Shi et al, 2019;Xiang et al, 2020). Whether Kushen or its active components influence T cell biology remains unclear.…”
Section: Discussionmentioning
confidence: 99%
“…Oxymatrine, an active component of Sophora flavescens, showed excellent anti-inflammatory and anti-psoriatic effects. To investigate the potential of oxymatrine in the treatment of psoriasis, Chen et al (Chen et al, 2017b) gathered 150 patients clinically diagnosed with psoriasis vulgaris from both inpatient and outpatient clinics. They were given 600 mg/kg oxymatrine intravenously for 4 weeks.…”
Section: Alkaloidsmentioning
confidence: 99%